Results of a pilot management protocol for screening-detected ASIL in HIV-negative women with a history of HPV-related gynaecological neoplasia
Background: Pending high-level evidence that ablative treatments of ASIL impact the incidence of anal cancer, it is appropriate to offer low-impost office-based treatments for biopsy-proven HSIL, in combination with close follow-up to monitor for disease persistence or progression.Methods: As part of a pilot screening program for ASIL in women Ski